Abstract
Purpose
Retroperitoneal sarcoma (RPS) is a rare tumor with a poor prognosis and is often undetected until it is significantly enlarged. While surgical resection remains the primary treatment, there is little research on its benefits, especially that concerning the reoperation of recurrent disease. This study investigated the impact of surgical procedures, especially reoperation of recurrent RPS, on prognosis.
Methods
This retrospective study included 51 patients who underwent radical resection surgery (R0 status) for primary or recurrent RPS without distant metastasis. Patient outcomes and prognosis were defined in terms of the clinicopathologic factors and surgical techniques performed.
Results
In all cases, the 5-year disease-free survival (DFS) rate was 28.2%, 5-year overall survival rate was 89.9%, and 5-year no residual liposarcoma rate was 54.3% after operation and re-reoperation. There was a statistically significant difference between the 5-year DFS rate and 5-year no residual liposarcoma rate due to frequent re-reoperation (p = 0.011). On univariate analysis of primary and recurrent lesions, the histological type and the number of organs involved were identified as statistically significant prognostic factors. Patients with well-differentiated liposarcomas had a statistically better prognosis than those with other cancer types (primary RPS, p = 0.028; recurrence, p = 0.024).
Conclusions
Aggressive and frequent resection of recurrent RPS with combined resection of adjacent organs contributes to long-term survival. The establishment of a surgical strategy for RPS will require a prospective study.
Similar content being viewed by others
References
Yuri T, Miyaso T, Kitade H, Takasu K, Shikata N, Takada H, Tsubura A (2011) Well-differentiated liposarcoma, an atypical lipomatous tumor, of the mesentery: a case report and review of the literature. Case Rep Oncol 4:178–185
Moyon FX, Moyon MA, Tufino JF, Yu A, Mafla OL, Molina GA. Massive retroperitoneal dedifferentiated liposarcoma in a young patient. J Surg Case Rep 2018;2018:rjy272
Matthyssens LE, Creytens D, Ceelen WP (2015) Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg 2:4
Kotilingam D, Lev DC, Lazar AJ, Pollock RE (2006) Staging soft tissue sarcoma: evolution and change. CA Cancer J Clin 56:282–291 quiz 314-5
Nathenson MJ, Barysauskas CM, Nathenson RA, Regine WF, Hanna N, Sausville E (2018) Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma. World J Surg Oncol 16:203
Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S (2006) Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244:381–391
Peterson MA (2003) Introduction: who shall lead? J Health Polit Policy Law 28:181–194
Trans-Atlantic RPSWG (2015) Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 22:256–263
Agrusa A, Di Buono G, Buscemi S et al (2019) Dedifferentiated retroperitoneal large liposarcoma and laparoscopic treatment: is it possible and safe? The first literature case report. Int J Surg Case Rep 57:113–117
Fletcher CDM, Hogendoorn P, Mertens F (2013) WHO classification of tumors of soft tissue and bone. Lyon: IARC Press:321–324
Nishimura J, Morii E, Takahashi T, Souma Y, Nakajima K, Doki Y, Nishida T (2010) Abdominal soft tissue sarcoma: a multicenter retrospective study. Int J Clin Oncol 15:399–405
Sassa N, Yokoyama Y, Nishida Y, Yamada S, Uchida H, Kajiyama H, Nagino M, Kodera Y, Gotoh M (2020) Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments. Int J Clin Oncol 25:929–936
Sato H, Minei S, Sugimoto S, Kishimoto Y, Yoshida T, Takimoto Y (2004) Multicentric liposarcoma. Int J Urol 11:1133–1135
Doyle LA (2014) Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer 120:1763–1774
Luo P, Cai W, Yang L, Wu Z, Chen Y, Zhang R, Yan W, Shi Y, Wang C (2018) Retroperitoneal dedifferentiated liposarcoma: analysis of 61 cases from a large institution. J Cancer 9:3831–3838
Tanaka K, Ozaki T (2019) New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG bone and soft tissue tumor study group. Jpn J Clin Oncol 49:103–107
Singer S, Antonescu CR, Riedel E, Brennan MF (2003) Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238:358–370 discussion 70-1
Ikeguchi M, Urushibara S, Shimoda R, Saito H, Wakatsuki T (2014) Surgical treatment of retroperitoneal liposarcoma. Yonago Acta Med 57:129–132
Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, Lozza L, Pennacchioli E, Mariani L, Casali PG (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27:24–30
Willis F, Schimmack S, Uhl M, Haefner MF, Mechtersheimer G, Hinz U, Schmidt T, Debus J, Fröhling S, Schneider M (2020) Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma. Eur J Surg Oncol 46:905–913
Bonvalot S, Rivoire M, Castaing M, Stoeckle E, le Cesne A, Blay JY, Laplanche A (2009) Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 27:31–37
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Ethical approval
This study was approved by the Ethics Committee of Aichi Cancer Center, Chikusa-ku Nagoya, Japan (2020-1-095).
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Material 1
A midline cutaneous incision is performed along with a transverse incision (PDF 916 kb)
Supplementary Material 2
The mechanism of unexpected massive bleeding during RPS resection (PDF 18 kb)
Rights and permissions
About this article
Cite this article
Komori, K., Tsukushi, S., Yoshida, M. et al. Aggressive and frequent resection of recurrences in retroperitoneal sarcoma contributes to long-term survival. Langenbecks Arch Surg 406, 1635–1642 (2021). https://doi.org/10.1007/s00423-020-02062-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-020-02062-z